Logo image of ZAL.DE

ZALANDO SE (ZAL.DE) Stock Fundamental Analysis

FRA:ZAL - Deutsche Boerse Ag - DE000ZAL1111 - Common Stock - Currency: EUR

32.85  -0.25 (-0.76%)

Fundamental Rating

5

Overall ZAL gets a fundamental rating of 5 out of 10. We evaluated ZAL against 54 industry peers in the Specialty Retail industry. ZAL has only an average score on both its financial health and profitability. ZAL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

ZAL had positive earnings in the past year.
ZAL had a positive operating cash flow in the past year.
Of the past 5 years ZAL 4 years were profitable.
Of the past 5 years ZAL 4 years had a positive operating cash flow.
ZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

1.2 Ratios

ZAL has a better Return On Assets (2.54%) than 69.81% of its industry peers.
ZAL's Return On Equity of 8.15% is fine compared to the rest of the industry. ZAL outperforms 69.81% of its industry peers.
With a decent Return On Invested Capital value of 4.76%, ZAL is doing good in the industry, outperforming 64.15% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ZAL is significantly below the industry average of 9.99%.
The last Return On Invested Capital (4.76%) for ZAL is above the 3 year average (2.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.54%
ROE 8.15%
ROIC 4.76%
ROA(3y)1.57%
ROA(5y)2.1%
ROE(3y)4.95%
ROE(5y)6.26%
ROIC(3y)2.83%
ROIC(5y)3.43%
ZAL.DE Yearly ROA, ROE, ROICZAL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

The Profit Margin of ZAL (1.98%) is better than 67.92% of its industry peers.
In the last couple of years the Profit Margin of ZAL has declined.
The Operating Margin of ZAL (3.62%) is better than 67.92% of its industry peers.
ZAL's Operating Margin has declined in the last couple of years.
ZAL's Gross Margin of 40.00% is fine compared to the rest of the industry. ZAL outperforms 60.38% of its industry peers.
ZAL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.62%
PM (TTM) 1.98%
GM 40%
OM growth 3Y-25.75%
OM growth 5Y-3.15%
PM growth 3Y-33.88%
PM growth 5Y-2.87%
GM growth 3Y-3.05%
GM growth 5Y-1.75%
ZAL.DE Yearly Profit, Operating, Gross MarginsZAL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZAL is destroying value.
There is no outstanding debt for ZAL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZAL.DE Yearly Shares OutstandingZAL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
ZAL.DE Yearly Total Debt VS Total AssetsZAL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.97 indicates that ZAL is not a great score, but indicates only limited risk for bankruptcy at the moment.
ZAL has a better Altman-Z score (2.97) than 79.25% of its industry peers.
ZAL has a debt to FCF ratio of 2.02. This is a good value and a sign of high solvency as ZAL would need 2.02 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.02, ZAL belongs to the best of the industry, outperforming 88.68% of the companies in the same industry.
ZAL has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
ZAL has a better Debt to Equity ratio (0.48) than 62.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 2.02
Altman-Z 2.97
ROIC/WACC0.77
WACC6.17%
ZAL.DE Yearly LT Debt VS Equity VS FCFZAL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.33 indicates that ZAL should not have too much problems paying its short term obligations.
ZAL has a Current ratio (1.33) which is comparable to the rest of the industry.
A Quick Ratio of 0.88 indicates that ZAL may have some problems paying its short term obligations.
ZAL has a Quick ratio of 0.88. This is in the better half of the industry: ZAL outperforms 73.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.88
ZAL.DE Yearly Current Assets VS Current LiabilitesZAL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

ZAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 131.47%, which is quite impressive.
The Earnings Per Share has been growing by 16.85% on average over the past years. This is quite good.
EPS 1Y (TTM)131.47%
EPS 3Y-5.94%
EPS 5Y16.85%
EPS Q2Q%-17.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.28%

3.2 Future

The Earnings Per Share is expected to grow by 33.24% on average over the next years. This is a very strong growth
ZAL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.12% yearly.
EPS Next Y58.78%
EPS Next 2Y41.39%
EPS Next 3Y33.87%
EPS Next 5Y33.24%
Revenue Next Year6.41%
Revenue Next 2Y6.01%
Revenue Next 3Y6.38%
Revenue Next 5Y8.12%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
ZAL.DE Yearly Revenue VS EstimatesZAL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
ZAL.DE Yearly EPS VS EstimatesZAL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 44.39, which means the current valuation is very expensive for ZAL.
Based on the Price/Earnings ratio, ZAL is valued a bit cheaper than the industry average as 62.26% of the companies are valued more expensively.
ZAL is valuated expensively when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 27.93, the valuation of ZAL can be described as expensive.
Based on the Price/Forward Earnings ratio, ZAL is valued a bit cheaper than 60.38% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ZAL is valued a bit more expensive.
Industry RankSector Rank
PE 44.39
Fwd PE 27.93
ZAL.DE Price Earnings VS Forward Price EarningsZAL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZAL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, ZAL is valued a bit cheaper than the industry average as 67.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.11
EV/EBITDA 11.12
ZAL.DE Per share dataZAL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZAL's earnings are expected to grow with 33.87% in the coming years.
PEG (NY)0.76
PEG (5Y)2.63
EPS Next 2Y41.39%
EPS Next 3Y33.87%

More info and screens

0

5. Dividend

5.1 Amount

ZAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZALANDO SE

FRA:ZAL (3/7/2025, 7:00:00 PM)

32.85

-0.25 (-0.76%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-06 2025-05-06
Inst Owners59.1%
Inst Owner ChangeN/A
Ins Owners10.08%
Ins Owner ChangeN/A
Market Cap8.68B
Analysts77.14
Price Target38.72 (17.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.04%
Min EPS beat(2)2.21%
Max EPS beat(2)61.86%
EPS beat(4)2
Avg EPS beat(4)-24.06%
Min EPS beat(4)-144.33%
Max EPS beat(4)61.86%
EPS beat(8)4
Avg EPS beat(8)-43.44%
EPS beat(12)5
Avg EPS beat(12)-91.43%
EPS beat(16)7
Avg EPS beat(16)-11.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)0.46%
Revenue beat(4)1
Avg Revenue beat(4)-1.11%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.46%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)2
Avg Revenue beat(12)-1.28%
Revenue beat(16)6
Avg Revenue beat(16)-0.64%
PT rev (1m)0.81%
PT rev (3m)8.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20%
EPS NY rev (1m)3.23%
EPS NY rev (3m)14.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.19%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 44.39
Fwd PE 27.93
P/S 0.84
P/FCF 10.11
P/OCF 7.79
P/B 3.46
P/tB 4.12
EV/EBITDA 11.12
EPS(TTM)0.74
EY2.25%
EPS(NY)1.18
Fwd EY3.58%
FCF(TTM)3.25
FCFY9.89%
OCF(TTM)4.22
OCFY12.84%
SpS39.11
BVpS9.49
TBVpS7.97
PEG (NY)0.76
PEG (5Y)2.63
Profitability
Industry RankSector Rank
ROA 2.54%
ROE 8.15%
ROCE 9.73%
ROIC 4.76%
ROICexc 13.47%
ROICexgc 19.11%
OM 3.62%
PM (TTM) 1.98%
GM 40%
FCFM 8.31%
ROA(3y)1.57%
ROA(5y)2.1%
ROE(3y)4.95%
ROE(5y)6.26%
ROIC(3y)2.83%
ROIC(5y)3.43%
ROICexc(3y)7.22%
ROICexc(5y)9.75%
ROICexgc(3y)9.06%
ROICexgc(5y)12.61%
ROCE(3y)5.78%
ROCE(5y)7.02%
ROICexcg growth 3Y-35.04%
ROICexcg growth 5Y-13.12%
ROICexc growth 3Y-34.39%
ROICexc growth 5Y-10.94%
OM growth 3Y-25.75%
OM growth 5Y-3.15%
PM growth 3Y-33.88%
PM growth 5Y-2.87%
GM growth 3Y-3.05%
GM growth 5Y-1.75%
F-Score7
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 2.02
Debt/EBITDA 1.7
Cap/Depr 77.3%
Cap/Sales 2.48%
Interest Coverage 250
Cash Conversion 157.99%
Profit Quality 420.33%
Current Ratio 1.33
Quick Ratio 0.88
Altman-Z 2.97
F-Score7
WACC6.17%
ROIC/WACC0.77
Cap/Depr(3y)114.16%
Cap/Depr(5y)123.68%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.41%
Profit Quality(3y)528.16%
Profit Quality(5y)345.58%
High Growth Momentum
Growth
EPS 1Y (TTM)131.47%
EPS 3Y-5.94%
EPS 5Y16.85%
EPS Q2Q%-17.61%
EPS Next Y58.78%
EPS Next 2Y41.39%
EPS Next 3Y33.87%
EPS Next 5Y33.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.28%
Revenue Next Year6.41%
Revenue Next 2Y6.01%
Revenue Next 3Y6.38%
Revenue Next 5Y8.12%
EBIT growth 1Y172.25%
EBIT growth 3Y-19.58%
EBIT growth 5Y9.91%
EBIT Next Year287.73%
EBIT Next 3Y70.06%
EBIT Next 5Y45.28%
FCF growth 1Y2202.7%
FCF growth 3Y35.27%
FCF growth 5YN/A
OCF growth 1Y208.76%
OCF growth 3Y21.65%
OCF growth 5Y34.87%